This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Daicel Corporation. Active years: 2023-2026.
Location History:
- Osaka, JP (2023)
- Tokyo, JP (2024)
Company Filing History:
Years Active: 2023-2026
Title: Shingo Atobe: Innovator in Biomolecular Injection Technology
Introduction
Shingo Atobe is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomolecular injection technology. His innovative approach aims to enhance the efficiency of injecting solutions containing biomolecules into targeted areas.
Latest Patents
Shingo Atobe holds a patent for an "Injector and method of injecting solution containing biomolecules into injection target using the same." This invention relates to an injector designed to maximize the proportion of biomolecules that effectively function within the injection target. The injector operates without requiring a specific structure to be inserted into the target during the injection process. This advancement is crucial for improving the delivery of biomolecules in medical applications.
Career Highlights
Atobe is currently associated with Daicel Corporation, where he continues to develop innovative solutions in the field of biomolecular technology. His work has garnered attention for its potential to revolutionize how biomolecules are administered in various medical treatments.
Collaborations
Shingo Atobe collaborates with notable colleagues, including Katsuya Miki and Hiroshi Miyazaki. Their combined expertise contributes to the advancement of technologies that enhance the effectiveness of biomolecular injections.
Conclusion
Shingo Atobe's contributions to biomolecular injection technology highlight his role as an influential inventor in the field. His innovative patent and ongoing work at Daicel Corporation demonstrate his commitment to improving medical solutions.